Chicago Partners Investment Group LLC Satsuma Pharmaceuticals, Inc. Transaction History

Chicago Partners Investment Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.61 - $5.06 $38,956 - $323,146	63,863 New	63,863 $57,000
Q4 2021 Feb 15, 2022	SELL	$4.15 - $6.24 $46,272 - $69,576	-11,150 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.54 - $7.17 $50,621 - $79,945	11,150 New	11,150 $51,000
Q4 2020 Jan 27, 2021	SELL	$3.56 - $5.09 $50,128 - $71,672	-14,081 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$3.85 - $28.47 $54,211 - $400,886	14,081 New	14,081 $52,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.